Trial intelligence / Profile preview

Immune Function and Muscle Adaptations to Resistance Exercise

NCT02261961Completed

Sponsor
VA Office of Research & Development
Start
Jul 2014
Primary completion
Dec 2018
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by VA Office of Research & Development. Primary endpoints: Change in Plasma Concentration of Antibodies to Pertussis Antigen, Change in Plasma Concentration of C-Reactive Protein at 2 weeks and 2 more. Started Jul 2014; status: completed.

Beyond the preview

Go deeper on NCT02261961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02261961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call